OASL
2'-5'-oligoadenylate synthase-like protein
Also known as: OASL_HUMAN, OASL1, p59OASL, TRIP14
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15646
- Gene
- OASL
- Ensembl
- ENSG00000135114
- Chromosome
- 12
- Canonical length
- 514 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables DNA binding activity and double-stranded RNA binding activity. Involved in several processes, including interleukin-27-mediated signaling pathway; negative regulation of viral genome replication; and positive regulation of RIG-I signaling pathway. Located in cytosol; nucleolus; and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
514 residues, UniProt reviewed canonical sequence.
>Q15646|OASL
1 MALMQELYST PASRLDSFVA QWLQPHREWK EEVLDAVRTV EEFLRQEHFQ GKRGLDQDVR
61 VLKVVKVGSF GNGTVLRSTR EVELVAFLSC FHSFQEAAKH HKDVLRLIWK TMWQSQDLLD
121 LGLEDLRMEQ RVPDALVFTI QTRGTAEPIT VTIVPAYRAL GPSLPNSQPP PEVYVSLIKA
181 CGGPGNFCPS FSELQRNFVK HRPTKLKSLL RLVKHWYQQY VKARSPRANL PPLYALELLT
241 IYAWEMGTEE DENFMLDEGF TTVMDLLLEY EVICIYWTKY YTLHNAIIED CVRKQLKKER
301 PIILDPADPT LNVAEGYRWD IVAQRASQCL KQDCCYDNRE NPISSWNVKR ARDIHLTVEQ
361 RGYPDFNLIV NPYEPIRKVK EKIRRTRGYS GLQRLSFQVP GSERQLLSSR CSLAKYGIFS
421 HTHIYLLETI PSEIQVFVKN PDGGSYAYAI NPNSFILGLK QQIEDQQGLP KKQQQLEFQG
481 QVLQDWLGLG IYGIQDSDTL ILSKKKGEAL FPASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OASL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 34 nTPM
- stomach: 21 nTPM
- lung: 11 nTPM
- liver: 7.7 nTPM
- urinary bladder: 7.2 nTPM
- colon: 7 nTPM
Single-cell type
- foveolar cells: 202 nCPM
- esophageal apical cells: 110 nCPM
- urothelial cells: 79 nCPM
- colonocytes: 65 nCPM
- t-cells: 48 nCPM
- goblet cells: 42 nCPM
Immune cell
- neutrophil: 133 nTPM
- eosinophil: 66 nTPM
- memory CD8 T-cell: 62 nTPM
- gdT-cell: 53 nTPM
- naive CD8 T-cell: 39 nTPM
- memory CD4 T-cell: 36 nTPM
Brain region
- spinal cord: 7.8 nTPM
- medulla oblongata: 4 nTPM
- pons: 3.9 nTPM
- thalamus: 3.3 nTPM
- white matter: 2.7 nTPM
- basal ganglia: 2.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.55
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antiviral innate immune response
- defense response to virus
- interleukin-27-mediated signaling pathway
- negative regulation of viral genome replication
- positive regulation of RIG-I signaling pathway
- response to virus
- type I interferon-mediated signaling pathway
Molecular functions
- DNA binding
- double-stranded RNA binding
- nuclear thyroid hormone receptor binding
- nucleotidyltransferase activity
- RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ubiquitin-like domain
- 2-5OAS/ClassI-CCAase, nucleotidyltransferase domain
- 2-5-oligoadenylate synthetase, C-terminal conserved site
- 2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal
- Ubiquitin-like domain superfamily
- 2-5-oligoadenylate synthetase, N-terminal conserved site
- Nucleotidyltransferase superfamily
- Ubiquitin family
- 2'-5'-oligoadenylate synthetase 1, domain 2, C-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OASL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OASL as an antibody target. Whether an autoantibody or antibody against OASL could matter depends on whether native OASL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OASL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OASL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...